|Day's Range||22.8000 - 22.9100|
|52 Week Range||17.6900 - 24.4300|
|PE Ratio (TTM)||12.61|
|Earnings Date||Jul 19, 2017 - Jul 24, 2017|
|Dividend & Yield||0.36 (1.55%)|
|1y Target Est||24.43|
PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PharmaMar (PHM) has announced today a licensing agreement with Eczacıbaşı Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey. Under the terms of the agreement, PharmaMar will receive an upfront payment as well as development milestones related to the health approval procedure of Aplidin® in this country. PharmaMar will retain exclusive production rights and will supply the finished product to Eczacıbaşı for commercial use.
Toll Brothers saw its IBD SmartSelect Composite Rating jump to 97 Wednesday, up from 91 the day before.